Zotiraciclib (TG02) for newly diagnosed glioblastoma in the elderly or for recurrent glioblastoma: The EORTC 1608 STEAM trial

  • Emilie Le Rhun*
  • , Thierry Gorlia
  • , Jörg Felsberg
  • , Joost Jongen
  • , Claude Alain Maurage
  • , François Ducray
  • , Dorothee Gramatzki
  • , Peter Hau
  • , Olivier L. Chinot
  • , Matthias Preusser
  • , Stephanie Cartalat
  • , Patrick Roth
  • , Martin van den Bent
  • , Julia Furtner
  • , Maike Collienne
  • , Guido Reifenberger
  • , Michael Weller
  • *Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

9 Citations (Scopus)
45 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Zotiraciclib (TG02) for newly diagnosed glioblastoma in the elderly or for recurrent glioblastoma: The EORTC 1608 STEAM trial'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science